Free Newsletters - Space - Defense - Environment - Energy - Solar - Nuclear
..
. Earth Science News .




EPIDEMICS
A mighty fighting flu breakthrough
by Staff Writers
Canberra, Australia (SPX) Feb 26, 2013


Dr Jenny McKimm-Breschkin showing drug killing viruses in cell culture.

The new drug has been proven to be effective in preventing the spread of different strains of influenza in laboratory models - including resistant strains of the virus.

The breakthrough is the result of a global collaboration between scientists from CSIRO, the University of British Columbia and the University of Bath.

In order to infect cells, flu viruses bind onto sugars on the cell surface. To be able to spread they need to remove these sugars. The new drug works by preventing the virus from removing sugars and blocking the virus from infecting more cells. It is hoped the drug will also be effective against future strains of the virus.

According to the World Health Organisation, influenza kills approximately 500,000 people each year, with up to 2500 of those deaths occurring in Australia[1]. Costs to the Australian health care system are estimated to be more than A$85M, with more than 1.5 million work days lost annually.

CSIRO scientist Dr Jenny McKimm-Breschkin, a researcher in the team that developed the first flu drug Relenza, said that understanding exactly how flu viruses become resistant to drugs has helped them to design a better flu drug.

"CSIRO researchers have shown that flu viruses continually mutate and some have become resistant to available treatments," Dr Jenny McKimm-Breschkin said.

"The new drug is effective against these resistant strains. As the site where the drug binds is found in all flu strains, the new drug is expected to be effective even against future flu strains.

"With millions of poultry currently infected with 'bird flu' globally, there are still concerns about its adaptation and potential to spread among humans, causing the next pandemic," she added.

Professor Steve Withers, University of British Columbia, has led the research team for the past seven years and said that although further studies are required to determine efficacy against a broader range of flu strains, the findings are extremely positive.

"Despite recent improvements in vaccine production, when a new strain of flu emerges it can take several months before vaccines are available to the public," Professor Steve Withers said.

"This antiviral drug would play an important role as the first line of defence in modulating disease severity and in controlling a pandemic while vaccines are prepared," he added.

Details of the research have been published in a paper titled: 'Mechanism-based Covalent Neuraminidase Inhibitors with Broad Spectrum Influenza Antiviral Activity'. Researchers estimate it will take up to seven years before the drug is released.

.


Related Links
CSIRO
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle




Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News





EPIDEMICS
Using transportation data to predict pandemics
Evanston IL (SPX) Feb 26, 2013
In a world of increasing global connections, predicting the spread of infectious diseases is more complicated than ever. Pandemics no longer follow the patterns they did centuries ago, when diseases swept through populations town by town; instead, they spread quickly and seemingly at random, spurred by the interactions of 3 billion air travelers per year. A computational model developed by ... read more


EPIDEMICS
Rio meet focuses on using science to root out poverty

British PM sparks concern with aid budget proposals

Swiss Re posts 61% profit rise in 2012

Four guilty of manslaughter in Italy quake trial

EPIDEMICS
Tokyo hotel shrinks in new-style urban demolition

Fluids in Space, Shaken Not Stirred

The world's most sensitive plasmon resonance sensor inspired by ancient Roman cup

Sustainable new catalysts fueled by a single proton

EPIDEMICS
Vibrant Mix of Marine Life Found at Extreme Ocean Depths

New projections of 'uneven' global sea-level rise

EU fisheries council tackles discard ban

Wiring the ocean

EPIDEMICS
Data paper describes Antarctic biodiversity data gathered by 90 expeditions since 1956

Frostbite ends Fiennes winter Antarctic expedition bid

Reduced sea ice disturbs balance of greenhouse gases

Flow of research on ice sheets helps answer climate questions

EPIDEMICS
Maize part of coastal Peru diet for 5,000 years

Why sourdough bread resists mold

Cold-tolerant grapes expand wine country

Bees attracted to contrasting colors when looking for nectar

EPIDEMICS
Earthquake shakes buildings in Tokyo

Australia's iron ore centre braces for Cyclone Rusty

Thousands isolated by Australian floodwaters

Gold gifts mystify tsunami-wracked Japan city

EPIDEMICS
Amnesty International accuses I. Coast army of abuses

Regional leaders sign peace deal for eastern DR Congo

Guinea soldiers quit I.Coast village in border dispute

Rising Islamist threat in West Africa

EPIDEMICS
High-tech brain is scientists' goal

How human language could have evolved from birdsong

Stay cool and live longer?

Zuckerberg, Brin join forces to extend life




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement